Pharmaids Pharmaceuticals informs about statement of deviations or variations

27 Apr 2023 Evaluate

Pursuant to the provisions of Regulation 32 of the Securities and Exchange Board of India [‘SEBI’] (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December 2019, Pharmaids Pharmaceuticals has confirmed that there is no deviation or variation in the use of proceeds of Preferential Issue of share Warrants. A ‘Nil’ Statement of Deviation, duly reviewed by the Audit Committee of the Company, is given in ‘Annexure A’. The proceeds raised by the Company through Preferential Issue have been utilised for the original objects as stated.

The above information is a part of company’s filings submitted to BSE.


Pharmaids Pharma Share Price

59.00 -1.49 (-2.46%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.